The effect of misoprostol, and metrogen with oxytocin in reducing of postpartum hemorrhage
Phase 3
- Conditions
- Postpartum hemorrhage.Postpartum hemorrhage
- Registration Number
- IRCT20230227057554N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 240
Inclusion Criteria
Singleton term pregnant women who have an indication for termination of pregnancy (37-40 weeks).
Have an indication for an elective cesarean section.
At least one risk factor for postpartum bleeding (such as polyhydramnios, multiparity, having a history of postpartum bleeding, macrosomia, and anemia).
Exclusion Criteria
Emergency cesarean section
Abnormal fetal heartbeat
Vaginal bleeding
Person with unexpected bleeding during the surgery
Severe anemia (hemoglobin less than 8 mg/dL) before surgery
Advanced underlying diseases
History of coagulation disorders
Low-lying placenta, decolman or accreta previa
Reaction history to the drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of postpartum hemorrhage. Timepoint: Once, six hours after the caesarean section. Method of measurement: Number of pads used in the first six hours after the caesarean section.
- Secondary Outcome Measures
Name Time Method Hemoglobin and hematocrit concentration. Timepoint: Once, six hours after the cesarean section. Method of measurement: Complete blood count.